Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Brazil to start vaccinating Jan 20, as UK bars travelers over new virus variant

Thu, 14th Jan 2021 13:35

(Adds regulators requesting more information on vaccines)

By Gabriel Stargardter and Ricardo Brito

RIO DE JANEIRO/BRASILIA, Jan 14 (Reuters) - Brazil aims to
begin nationwide COVID-19 vaccinations on Jan. 20, the head of
the national mayor's association said on Thursday, as Britain
banned arrivals from the country over fears of a new homegrown
coronavirus variant.

President Jair Bolsonaro, who has been lambasted for
downplaying the severity of the world's second-deadliest
COVID-19 outbreak, is under mounting pressure to begin
vaccinations as a second wave of infections surpasses the first.

He also faces the prospect of international isolation after
Britain said it would ban travelers from Brazil, several other
South American countries and Portugal over fears of the new
virus variant.

Japan's health ministry said on Sunday it had detected the
new variant in four travelers from Brazil's northern Amazonas
state. This one features 12 mutations, including one also found
in highly infections variants recently discovered in Britain and
South Africa that have begun circulating around the globe.

Researchers from the Oswaldo Cruz Amazônia Foundation said
this week the new variant found in Japan likely appeared in
northern Brazil between December and January. They said it could
be contributing to the sharp rise in cases in Amazonas state,
although they were conducting more studies to ascertain if it is
more contagious than earlier versions of the coronavirus.

The state of Amazonas, where nearly 6,000 people have died
from COVID-19, is now suffering a devastating second wave that
is pushing emergency services to a breaking point.

Jarbas Barbosa, assistant director of the Pan American
Health Organization, was not ready to pin the surge in
infections in Amazonas on the new variant.

"It is happening also in many different cities and states,
probably due to the holidays, the summer, with more travels and
people going out, and the relaxation of social distancing
measures," Barbosa said.

VACCINE ROLLOUT

Jonas Donizette, the president of the national mayor's
association, said in a statement on Thursday that vaccinations
would begin on Wednesday if all goes as the government plans.

"If it's not on the 20th, for whatever logistical problem,
it will be on Thursday 21," he wrote. "Inoculations will begin
with 8 million doses, distributed to 5 million Brazilians."

The government is planning a Jan. 19 ceremony to mark the
start of inoculations, according to a source involved in the
plan.

While the government has declined to give an official start
date for vaccinations, it has said inoculations could not begin
before Jan. 20. The Health Ministry did not respond to a request
for comment.

Two vaccines - one made by AstraZeneca Plc and
another developed by China's Sinovac Biotech - will form
the bedrock of the government's vaccination plan. Both have
applied for emergency use in Brazil, with health regulator
Anvisa expected to decide on Sunday whether to authorize them.

Anvisa said on Thursday it had asked for missing information
from Brazilian biomedical centers that are partnered with the
vaccine developers, Fiocruz and Butantan. In the case of
Butantan, Anvisa requested additional efficacy data from Phase
III trials of the Chinese vaccine done in Brazil.

Vaccination of the country's population will take 16 months
at most, Deputy Health Minister Elcio Franco said at a news
conference on Wednesday.

Brazil has already imported 6 million doses of the Sinovac
vaccine and is sending a plane to pick up 2 million doses of the
AstraZeneca vaccine, made by India's Serum Institute.

The Health Ministry said the plane's departure from Recife
in northeastern Brazil had been delayed until late on Friday.

(Reporting by Gabriel Stargardter and Ricardo Brito; Additional
reporting by Pedro Fonseca and Eduardo Simoes
Editing by Nick Macfie and Bill Berkrot)

More News
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.